monoclonal antibody

Proteos Recombinant Antibody Production

Recombinant Antibody Production: The Argument Against Hybridomas

1/26/2021

Proteos is an industry leader in the production of high-quality recombinant antibodies for drug discovery research.  There are multiple methods for production of monoclonal antibodies, including hybridoma cell lines and recombinant protein technology.  The following information will discuss some of the limitations of hybridoma production.

Tags: IgG, mab, monoclonal antibody, Protein A purification, Recombinant antibody production, transient mammalian expression

Proteos booth information - Antibody Engineering & Therapeutics 2017

Antibody Engineering & Therapeutics 2017 – Proteos Booth # 221 – December 11-15

12/11/2017

Proteos will be exhibiting at the Antibody Engineering & Therapeutics conference.  Please stop by booth #221 to learn why Proteos is an industry leader in the production of high-quality recombinant proteins and antibodies.

Tags: IgG, mab, monoclonal antibody, Protein A purification, Recombinant antibody production, transient mammalian expression

Customize This